DN-1289
DN-1289 is an orally active and selective inhibitor of dual leucine zipper kinase (DLK; IC50=17 nM) and leucine zipper-bearing kinase (LZK; IC50=40 nM) . DN-1289 results significant attenuation of optic nerve crush (ONC) -induced p-c-Jun in mice model. DN-1289 has excellent in vivo plasma half-life and blood-brain barrier permeability[1].
Product Specifications
CAS Number
3026597-15-6
UNSPSC
12352005
Target
JNK
Type
Reference compound
Related Pathways
MAPK/ERK Pathway
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/dn-1289.html
Purity
99.63
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
NC1=C(OC(F)F)N=C(C2=NC(N3[C@@H](C4)CO[C@@H]4C3)=NC(N5CCC(F)(F)C5)=C2)C=N1
Molecular Formula
C18H19F4N7O2
Molecular Weight
441.38
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Ɑ-Butyric Acid NHS Ester-ω-Maleimidohexanamido PEG
![FGF2 Recombinant Rabbit Monoclonal Antibody [JM28-10]](https://cdn.genprice.uk/products/992/68dd1c8b061270361ea81429/imageurl/et1703-18.webp)
FGF2 Recombinant Rabbit Monoclonal Antibody [JM28-10]
